Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

DC-based TaReNef AIDS vaccine is safe and immunogenic in phase I/II trial

Oct. 13, 2010

AGI-101 improves postsurgery survival in high-risk melanoma

Oct. 11, 2010

Tasocitinib meets primary endpoint in phase II psoriasis trial

Oct. 11, 2010

PP-9706642 shows promise as a prophylactic/therapeutic agent for HSV-2 infection

Oct. 11, 2010

Debio-0719 suppresses metastasis in mouse models of breast cancer

Oct. 11, 2010

PTC-299/aromatase inhibitor combinations deemed feasible in breast cancer trial

Oct. 11, 2010

MV-062926 is active in mouse model of COPD

Oct. 8, 2010

Eisai details in vitro and in vivo activity of new antifungal E-1210

Oct. 8, 2010

Extended proof-of-concept and drug interaction studies complete for IDX-899

Oct. 8, 2010

Preclinical and early clinical data reported on BC-3781

Oct. 8, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...